SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.373
NA - Nord America 12.117
AS - Asia 6.296
SA - Sud America 901
Continente sconosciuto - Info sul continente non disponibili 219
AF - Africa 193
OC - Oceania 55
Totale 39.154
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.003
US - Stati Uniti d'America 11.638
SG - Singapore 1.787
CN - Cina 1.671
GB - Regno Unito 1.360
BR - Brasile 669
HK - Hong Kong 657
VN - Vietnam 624
NL - Olanda 570
DE - Germania 401
BD - Bangladesh 388
SE - Svezia 366
FR - Francia 342
FI - Finlandia 270
CA - Canada 249
RU - Federazione Russa 247
KR - Corea 238
UA - Ucraina 188
TR - Turchia 187
IN - India 147
ID - Indonesia 129
AR - Argentina 87
CH - Svizzera 86
ES - Italia 84
MX - Messico 84
JP - Giappone 81
IE - Irlanda 75
BG - Bulgaria 62
PL - Polonia 60
IQ - Iraq 53
ZA - Sudafrica 51
AU - Australia 48
AT - Austria 44
PK - Pakistan 37
MA - Marocco 34
BE - Belgio 33
CO - Colombia 33
MY - Malesia 33
IL - Israele 32
PH - Filippine 27
AE - Emirati Arabi Uniti 25
VE - Venezuela 25
IR - Iran 24
EG - Egitto 23
NO - Norvegia 23
CR - Costa Rica 22
CZ - Repubblica Ceca 22
EC - Ecuador 22
TW - Taiwan 22
CL - Cile 21
LT - Lituania 21
RO - Romania 20
GT - Guatemala 19
PE - Perù 19
SA - Arabia Saudita 19
SV - El Salvador 16
GR - Grecia 15
KE - Kenya 15
TH - Thailandia 14
AL - Albania 13
HN - Honduras 13
MT - Malta 13
NP - Nepal 12
SC - Seychelles 12
TT - Trinidad e Tobago 12
CW - ???statistics.table.value.countryCode.CW??? 11
PR - Porto Rico 11
PY - Paraguay 11
DZ - Algeria 10
KZ - Kazakistan 10
NI - Nicaragua 10
UZ - Uzbekistan 10
BH - Bahrain 9
BO - Bolivia 9
PT - Portogallo 9
TN - Tunisia 9
AZ - Azerbaigian 7
BZ - Belize 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
OM - Oman 7
BB - Barbados 6
GP - Guadalupe 6
JM - Giamaica 6
JO - Giordania 6
LV - Lettonia 6
BY - Bielorussia 5
KG - Kirghizistan 5
MK - Macedonia 5
PA - Panama 5
RS - Serbia 5
SN - Senegal 5
AM - Armenia 4
NG - Nigeria 4
QA - Qatar 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
CI - Costa d'Avorio 3
Totale 38.878
Salva come PNG Salva come JPEG
Città #
Ashburn 1.747
Rome 1.313
Santa Clara 1.283
Milan 1.216
Singapore 1.120
San Jose 1.023
Southend 872
Hefei 655
Hong Kong 644
Council Bluffs 516
Naples 502
Fairfield 428
Chandler 408
Bologna 367
Florence 344
Turin 314
Woodbridge 260
Houston 256
Jacksonville 256
Los Angeles 252
London 250
Seoul 225
Bari 223
Beijing 216
Ho Chi Minh City 210
Nyköping 199
Dearborn 197
Helsinki 189
Chicago 188
New York 186
Ann Arbor 180
Wilmington 173
Modena 168
Seattle 160
The Dalles 158
Catania 155
Parma 150
Genoa 149
Palermo 148
Hanoi 139
Cambridge 114
São Paulo 114
Verona 113
Buffalo 105
Brescia 97
Izmir 92
Jakarta 92
Lauterbourg 89
Dallas 87
Moscow 83
Padova 83
Cagliari 82
Reggio Emilia 79
Pescara 76
Shanghai 75
Munich 71
Princeton 68
San Diego 66
Toronto 65
Orem 63
Salt Lake City 61
Trieste 59
Livorno 58
Sofia 57
Tokyo 56
Boardman 54
Columbus 54
Rimini 52
Vicenza 52
Trento 51
Frankfurt am Main 48
Mexico City 48
Perugia 46
Eugene 44
Tampa 42
Des Moines 38
Venice 38
Elk Grove Village 37
Montreal 37
Phoenix 36
Ancona 35
Atlanta 35
Bremen 35
Kent 35
Da Nang 34
Monza 34
Amsterdam 33
Brooklyn 33
Dublin 33
Taranto 33
Treviso 33
Denver 32
Ottawa 32
Redwood City 32
Salerno 32
Messina 31
Paris 31
Lucca 29
Warsaw 29
Bergamo 28
Totale 20.770
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.932
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.879
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.994
Farmaci biologici e infezione tubercolare 615
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 497
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 435
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 408
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 379
Biological Therapy and Risk of Malignancies: A Literature Review 378
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 369
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 369
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 355
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 338
HCV associated cryoglobulinemic vasculitis 337
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 336
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 332
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 331
Non HCV-related mixed cryoglobulinemia 331
Early Occupational Therapy Intervention: Patients’ Occupational Needs 331
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 325
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 313
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 312
EULAR guidelines on ANCA-associated vasculitis in the real life 301
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 296
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 288
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 284
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 281
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 281
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 278
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 277
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 273
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 270
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 269
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 269
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 268
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 262
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 262
Sanitary costs of osteoarthritis 256
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 254
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 253
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 253
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 252
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 251
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 246
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 244
Farmaci biologici ed epatiti da virus B e C 242
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 241
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 240
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 240
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 239
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 235
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 234
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 229
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 227
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 223
On- and off-label use of rituximab in rheumatic diseases 223
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 222
Endothelial Dysfunction in Acute Hepatic Porphyrias 220
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 218
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 216
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 216
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 216
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 214
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 212
Cryofibrinogen: A possibile risk factor in systemic sclerosis 211
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 210
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 207
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 204
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 204
Cryoproteinemia: new frontiers for clinicians and the laboratory 203
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 201
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 201
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 198
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 191
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 191
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 187
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 184
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 183
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 177
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 176
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 174
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 174
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 171
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 171
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 170
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 164
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 164
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 163
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 162
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 160
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 160
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 156
The management of large vessel vasculitides 153
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 149
Buerger's disease or thromboangiitis obliterans: description of two cases 149
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 147
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 137
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 136
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 135
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 129
Totale 37.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.048 0 0 0 0 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/202611.424 832 616 1.051 1.492 1.377 693 1.256 594 958 951 894 710
2026/20274.198 475 825 1.105 1.487 306 0 0 0 0 0 0 0
Totale 39.154